Blood Metabolites and Gastric Cancer Risk
Author Information
Author(s): Qian Lei, Song Jiawei, Zhang Xiaoqun, Qiao Yihuan, Tan Zhaobang, Li Shisen, Zhu Jun, Li Jipeng
Primary Institution: Fourth Military Medical University, Xi'an, China
Hypothesis
Is there a causal relationship between genetically predicted blood metabolites and the risk of gastric cancer?
Conclusion
Three blood metabolites are causally related to gastric cancer, suggesting their potential as biomarkers for early detection and intervention.
Supporting Evidence
- Elevated levels of tryptophan, nonadecanoate (19:0), and erythritol are associated with a decreased risk of gastric cancer.
- Blood samples from gastric cancer patients showed reduced levels of these metabolites compared to healthy controls.
- The study utilized advanced metabolomics techniques to analyze blood samples.
Takeaway
This study found that certain blood substances can help protect against stomach cancer, and measuring them might help doctors catch the disease early.
Methodology
The study used Mendelian randomization and metabolomics techniques to analyze blood samples from gastric cancer patients and healthy controls.
Potential Biases
The SNPs selected are unlikely to influence outcomes through pathways unrelated to the metabolites of interest.
Limitations
The study did not account for potential confounding factors like smoking and alcohol consumption.
Participant Demographics
11 gastric cancer patients and 11 healthy controls, all from Xi'an, China.
Statistical Information
P-Value
0.013
Confidence Interval
0.313–0.872
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website